FR2453650A1 - Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes - Google Patents

Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes

Info

Publication number
FR2453650A1
FR2453650A1 FR8008053A FR8008053A FR2453650A1 FR 2453650 A1 FR2453650 A1 FR 2453650A1 FR 8008053 A FR8008053 A FR 8008053A FR 8008053 A FR8008053 A FR 8008053A FR 2453650 A1 FR2453650 A1 FR 2453650A1
Authority
FR
France
Prior art keywords
cholecalciferol
bone metabolism
homeothermes
useful
medicament based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8008053A
Other languages
English (en)
Other versions
FR2453650B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of FR2453650A1 publication Critical patent/FR2453650A1/fr
Application granted granted Critical
Publication of FR2453650B1 publication Critical patent/FR2453650B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE UN MEDICAMENT CONTENANT, COMME SUBSTANCES ACTIVES, DES DERIVES DU CHOLECALCIFEROL. CE MEDICAMENT RENFERME DU DIHYDROXY-1A, 24 CHOLECALCIFEROL ET DU DIHYDROXY-24, 25 CHOLECALCIFEROL AINSI QU'UN EXCIPIENT ACCEPTABLE DU POINT DE VUE PHARMACEUTIQUE. IL PEUT ETRE PRESENTE EN UNITES DE PRISE ADMINISTRABLE PAR LA VOIE ORALE. IL PEUT SERVIR NOTAMMENT AU TRAITEMENT PREVENTIF OU CURATIF DE TROUBLES DU METABOLISME OSSEUX CHEZ L'HOMME OU CHEZ L'ANIMAL HOMEOTHERME. ON PEUT L'ADMINISTRER EN TOUTE SECURITE PENDANT LONGTEMPS, PAR EXEMPLE POUR LE TRAITEMENT DE L'OSTEOPOROSE, CAR ON N'OBSERVE PAS D'EFFET DEFAVORABLE NOTABLE DU 1A,24-DHCC SUR LE METABOLISME DU 24,25-DHCC.
FR8008053A 1979-04-10 1980-04-10 Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes Granted FR2453650A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4244779A JPS55136229A (en) 1979-04-10 1979-04-10 Adjustment of bone metabolism in warm-blooded animal and drug for it

Publications (2)

Publication Number Publication Date
FR2453650A1 true FR2453650A1 (fr) 1980-11-07
FR2453650B1 FR2453650B1 (fr) 1983-04-29

Family

ID=12636321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8008053A Granted FR2453650A1 (fr) 1979-04-10 1980-04-10 Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes

Country Status (6)

Country Link
US (1) US4364941A (fr)
JP (1) JPS55136229A (fr)
CH (1) CH644518A5 (fr)
DE (1) DE3013632A1 (fr)
FR (1) FR2453650A1 (fr)
GB (1) GB2047536B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498450A1 (fr) * 1981-01-28 1982-07-30 Abbott Lab Composition phamaceutique aqueuse diluee stabilisee pour l'administration du 1a, 25-dihydroxycholecalciferol a des nouveau-nes
EP0301167A1 (fr) * 1987-07-22 1989-02-01 Teva Pharmaceutical Industries Limited Un mélange des dérivés de cholecalciférol pour le traitement des maladies ostéorénales

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442093A (en) * 1981-05-15 1984-04-10 Kureha Kagaku Kogyo Kabushiki Kaisha Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
JPS58185519A (ja) * 1982-04-15 1983-10-29 Kureha Chem Ind Co Ltd 抗高燐血症剤
US4568550A (en) * 1981-09-08 1986-02-04 General Foods Corporation Process for preparing a cooked extruded flour-based product
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JPS6089422A (ja) * 1983-10-24 1985-05-20 Kureha Chem Ind Co Ltd 抗骨粗鬆症剤
JPS60120812A (ja) * 1983-12-02 1985-06-28 Teijin Ltd 糖尿病性骨減少症治療剤
CA1272953A (fr) * 1984-10-08 1990-08-21 Yuji Makino Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
CA1317546C (fr) * 1985-07-01 1993-05-11 Werner Meier Preparations pharmaceutiques contenant un melange de derives hydroxy de la vitamine d
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
EP0914825B1 (fr) * 1991-01-08 2003-05-21 Bone Care International, Inc. Procédé de préparation de la 1 alpha 24-dihydroxy vitamine D2
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5168557A (en) * 1974-12-09 1976-06-14 Teijin Ltd 1 arufua 244 jihidorokishikorekarushifuerooruno seizoho
US4021423A (en) * 1976-03-08 1977-05-03 Hoffmann-La Roche Inc. Syntheses of 24R,25- and 24S,25-dihydroxycholecalciferol
JPS5326316A (en) * 1976-08-20 1978-03-11 Teijin Ltd Drug containing active vitamin d3 derivatives and its preparation
JPS5524105A (en) * 1978-08-09 1980-02-21 Teijin Ltd Method and agent for control of calcium metabolism of warm-blooded animal

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA1977 *
CA1978 *
EXBK/78 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498450A1 (fr) * 1981-01-28 1982-07-30 Abbott Lab Composition phamaceutique aqueuse diluee stabilisee pour l'administration du 1a, 25-dihydroxycholecalciferol a des nouveau-nes
EP0301167A1 (fr) * 1987-07-22 1989-02-01 Teva Pharmaceutical Industries Limited Un mélange des dérivés de cholecalciférol pour le traitement des maladies ostéorénales
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease

Also Published As

Publication number Publication date
GB2047536B (en) 1984-01-25
DE3013632A1 (de) 1980-11-20
US4364941A (en) 1982-12-21
JPS55136229A (en) 1980-10-23
GB2047536A (en) 1980-12-03
FR2453650B1 (fr) 1983-04-29
CH644518A5 (de) 1984-08-15

Similar Documents

Publication Publication Date Title
FR2453650A1 (fr) Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes
Weissmann Aspirin
ATE279185T1 (de) 2-amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-di l enthaltendes arzneimittel zur topischen anwendung zur behandlung von erkrankungen die durch eine störung des immunsystems hervorgerufen werden
DK420385D0 (da) Antioestrogent laegemiddel til perkutan indgift
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
DE69602412T2 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
FR2711140B1 (fr) 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
KR970061244A (ko) 치매 치료용 약학 조성물
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
FR2712809B1 (fr) Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
JPS60120995A (ja) 新規アミノ酸誘導体の製法
ATE40793T1 (de) Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen.
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
FR2421173A1 (fr) 2-(4-ethylpiperazino)-4-phenylquinoleine et ses sels, utiles notamment comme antidepresseurs, et leur procede de preparation
EP0402208B1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
DE3688787D1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
RU2180565C2 (ru) Препарат для профилактики и лечения эндометрита
RU2141308C1 (ru) Лекарственное средство для лечения грибковых заболеваний полости рта
EP0252033B1 (fr) Une forme galénique "gel" contenant de l'acide N-(2,6-dichloro-m-tolyl) anthranilique (acide mechlophénamique) pour utilisation dans la thérapie locale
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
RU2071316C1 (ru) Глазные капли для лечения катаракты
RU2238099C1 (ru) Лекарственное средство для лечения заболеваний опорно-двигательного аппарата
RU2150959C1 (ru) Способ профилактики и лечения желудочно-кишечных болезней у молодняка свиней
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse